EAM Investors LLC purchased a new position in PetMed Express, Inc. (NASDAQ:PETS) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 97,536 shares of the company’s stock, valued at approximately $3,960,000. PetMed Express comprises 0.7% of EAM Investors LLC’s investment portfolio, making the stock its 25th largest position. EAM Investors LLC owned about 0.48% of PetMed Express as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of PETS. Acrospire Investment Management LLC acquired a new stake in PetMed Express in the 2nd quarter worth $110,000. Pinebridge Investments L.P. grew its position in PetMed Express by 1.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after purchasing an additional 27 shares during the last quarter. Westside Investment Management Inc. grew its position in PetMed Express by 15.8% in the 1st quarter. Westside Investment Management Inc. now owns 5,502 shares of the company’s stock worth $114,000 after purchasing an additional 752 shares during the last quarter. State of Alaska Department of Revenue grew its position in PetMed Express by 76.7% in the 2nd quarter. State of Alaska Department of Revenue now owns 4,028 shares of the company’s stock worth $163,000 after purchasing an additional 1,748 shares during the last quarter. Finally, Arizona State Retirement System grew its position in PetMed Express by 0.9% in the 1st quarter. Arizona State Retirement System now owns 10,667 shares of the company’s stock worth $215,000 after purchasing an additional 100 shares during the last quarter. Institutional investors own 78.91% of the company’s stock.

Several analysts have issued reports on the stock. Northcoast Research upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price target on the stock in a research report on Monday, July 24th. Noble Financial restated a “hold” rating on shares of PetMed Express in a research report on Wednesday, July 26th. Craig Hallum restated a “hold” rating and issued a $40.00 price target (down from $43.00) on shares of PetMed Express in a research report on Monday, August 21st. They noted that the move was a valuation call. BidaskClub lowered shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, August 22nd. Finally, Sidoti upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price target on the stock in a research report on Thursday, August 24th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $44.75.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/09/24/eam-investors-llc-invests-3-96-million-in-petmed-express-inc-pets-stock.html.

Shares of PetMed Express, Inc. (NASDAQ PETS) traded down 1.45% during mid-day trading on Friday, hitting $35.33. 736,497 shares of the stock traded hands. The company’s 50 day moving average is $40.97 and its 200 day moving average is $33.60. PetMed Express, Inc. has a one year low of $18.90 and a one year high of $50.90. The firm has a market capitalization of $716.92 million, a P/E ratio of 27.18 and a beta of 1.03.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, July 24th. The company reported $0.45 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.07. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The company had revenue of $79.66 million for the quarter, compared to analyst estimates of $77.32 million. During the same period in the prior year, the firm earned $0.32 earnings per share. The company’s revenue was up 9.9% on a year-over-year basis. On average, equities analysts expect that PetMed Express, Inc. will post $1.44 EPS for the current fiscal year.

In related news, Director Robert C. Schweitzer sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $49.18, for a total transaction of $122,950.00. Following the transaction, the director now directly owns 88,834 shares of the company’s stock, valued at $4,368,856.12. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Bruce S. Rosenbloom sold 6,833 shares of the firm’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $50.18, for a total transaction of $342,879.94. Following the transaction, the chief financial officer now directly owns 18,534 shares in the company, valued at $930,036.12. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 19,333 shares of company stock worth $949,730. 4.00% of the stock is owned by insiders.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS).

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.